From: Risk of developing depression among breast cancer patients in Palestine
Variable | Participants n (%) | Asymptomatic-mild depression | Moderate-severe depression | P- value |
---|---|---|---|---|
Knowledge of BC stage or type | ||||
Yes | 35 (15.7%) | 17 (48.6%) | 18 (51.4%) | 0.031 |
No | 188 (84.3%) | 127 (67.6%) | 61 (32.4%) | |
Treatment plan | ||||
+ Chemo | 203 (91.0%) | 130 (64.0%) | 73 (36.0%) | 0.595 |
-Chemo | 20 (9.0%) | 14 (70.0%) | 6 (30.0%) | |
Surgery Type | ||||
Partial (± LN) | 119 (53.4%) | 74 (62.2%) | 45 (37.8%) | 0.147 |
Total (± LN) | 77 (34.5%) | 48 (62.3%) | 29 (37.7%) | |
No surgery | 27 (12.1%) | 22 (81.5%) | 5 (18.5%) | |
Number of side effects due to chemotherapy | ||||
0 to 3 | 135 (60.5%) | 96 (71.1%) | 39 (28.9%) | 0.011 |
4 to 7 | 88 (39.5%) | 48 (54.5%) | 40 (45.5%) | |
Chemotherapy-induced alopecia | ||||
Hair loss | 164 (73.5%) | 101 (61.6%) | 63 (38.4%) | 0.120 |
No Hair loss | 59 (26.5%) | 43 (72.9%) | 16 (27.1%) |